Scytonemin inhibits cell proliferation and arrests cell cycle through downregulating Plk1 activity in multiple myeloma cells

Enhanced gemcitabine-mediated cell killing of human lung adenocarcinoma by vector-based RNA interference against PLK1

(2012) Xin-Yu Zhao et al.   BIOMEDICINE & PHARMACOTHERAPY

Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer

(2012) V. Maire et al.   CANCER RESEARCH

Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity

(2012) Kelley Salem et al.   EXPERIMENTAL HEMATOLOGY

High Mitotic Activity of Polo-like Kinase 1 Is Required for Chromosome Segregation and Genomic Integrity in Human Epithelial Cells

(2012) Robert F. Lera et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development

(2012) Jijing Luo et al.   Protein & Cell

Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo

(2011) Xianzhe Liu et al.   ANTI-CANCER DRUGS

Reciprocal Activation Between PLK1 and Stat3 Contributes to Survival and Proliferation of Esophageal Cancer Cells

(2011) Yu Zhang et al.   GASTROENTEROLOGY

High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder

(2011) Zhe Zhang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

A role for Drosophila Polo protein in chromosome resolution and segregation during mitosis

(2010) Susana Godinho et al.   CELL CYCLE

Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells

(2009) A. G. Renner et al.   BLOOD